Media Summary: Dr. Bill Moss, executive director of the International "This data doesn't prove anything, it just suggests that CNBC's David Faber, Meg Tirrell and Jim Cramer discuss

Moderna Is Curbing Investment In Vaccine Trials Due To Us Backlash - Detailed Analysis & Overview

Dr. Bill Moss, executive director of the International "This data doesn't prove anything, it just suggests that CNBC's David Faber, Meg Tirrell and Jim Cramer discuss Yahoo Finance's Anjalee Khemlani breaks down the latest on A lot of Americans are planning on getting both a flu shot and Covid booster this fall. But Yahoo Finance's Anjalee Khemlani joins Zack Guzman to discuss the outlook for

Photo Gallery

Moderna is curbing investment in vaccine trials due to US backlash
Moderna downsizing investments in late-stage vaccine trials amid U.S. skepticism
Moderna Co-founder on Impact of Cuts to Vaccine Research
Shares of Moderna rally on vaccine news, CEO discusses vaccine trial and efficacy
Moderna stock declines on mixed flu vaccine trial results
Moderna defends COVID-19 vaccine price hike before U.S. Senate
Moderna president outlines progress in vaccine trials
Moderna's vaccine trials bring hope as more states resume pandemic restrictions
Moderna, Johnson & Johnson advance human vaccine trials in U.S.
Jim Cramer breaks down how Moderna vaccine progress sparked stocks to rally
Participants In Moderna's COVID Vaccine Trial Speak Out About Importance Of Vaccine, Short-term Side
Jim Cramer: Moderna could have been more transparent about needing funds for vaccine trial
Sponsored
Sponsored
View Detailed Profile
Moderna is curbing investment in vaccine trials due to US backlash

Moderna is curbing investment in vaccine trials due to US backlash

Moderna

Moderna downsizing investments in late-stage vaccine trials amid U.S. skepticism

Moderna downsizing investments in late-stage vaccine trials amid U.S. skepticism

Pharmaceutical company

Sponsored
Moderna Co-founder on Impact of Cuts to Vaccine Research

Moderna Co-founder on Impact of Cuts to Vaccine Research

Noubar Afeyan, co-founder of COVID

Shares of Moderna rally on vaccine news, CEO discusses vaccine trial and efficacy

Shares of Moderna rally on vaccine news, CEO discusses vaccine trial and efficacy

Moderna

Moderna stock declines on mixed flu vaccine trial results

Moderna stock declines on mixed flu vaccine trial results

Moderna

Sponsored
Moderna defends COVID-19 vaccine price hike before U.S. Senate

Moderna defends COVID-19 vaccine price hike before U.S. Senate

Moderna

Moderna president outlines progress in vaccine trials

Moderna president outlines progress in vaccine trials

President of biotech firm

Moderna's vaccine trials bring hope as more states resume pandemic restrictions

Moderna's vaccine trials bring hope as more states resume pandemic restrictions

The

Moderna, Johnson & Johnson advance human vaccine trials in U.S.

Moderna, Johnson & Johnson advance human vaccine trials in U.S.

Dr. Bill Moss, executive director of the International

Jim Cramer breaks down how Moderna vaccine progress sparked stocks to rally

Jim Cramer breaks down how Moderna vaccine progress sparked stocks to rally

"This data doesn't prove anything, it just suggests that

Participants In Moderna's COVID Vaccine Trial Speak Out About Importance Of Vaccine, Short-term Side

Participants In Moderna's COVID Vaccine Trial Speak Out About Importance Of Vaccine, Short-term Side

WBZ-TV's Beth Germano.

Jim Cramer: Moderna could have been more transparent about needing funds for vaccine trial

Jim Cramer: Moderna could have been more transparent about needing funds for vaccine trial

CNBC's David Faber, Meg Tirrell and Jim Cramer discuss

Moderna’s COVID Vaccine Trial Slowed

Moderna’s COVID Vaccine Trial Slowed

One of the most promising COVID

Moderna CEO on kick off of phase three Covid-19 vaccine trial

Moderna CEO on kick off of phase three Covid-19 vaccine trial

Moderna

Moderna CEO discusses COVID-19 risks, vaccine boosters, MRNA technology and more

Moderna CEO discusses COVID-19 risks, vaccine boosters, MRNA technology and more

Moderna

Coronavirus vaccine: Moderna CEO talks vaccine pricing, human testing begins and COVID-19 cases rise

Coronavirus vaccine: Moderna CEO talks vaccine pricing, human testing begins and COVID-19 cases rise

Yahoo Finance's Anjalee Khemlani breaks down the latest on

Moderna CEO on combo Covid, flu vaccine moving to next trial phase

Moderna CEO on combo Covid, flu vaccine moving to next trial phase

A lot of Americans are planning on getting both a flu shot and Covid booster this fall. But

Moderna begins coronavirus vaccine trials for children

Moderna begins coronavirus vaccine trials for children

Moderna

New Moderna Vaccine Shows Promise As US Hits 11 Million Coronavirus Cases | TODAY

New Moderna Vaccine Shows Promise As US Hits 11 Million Coronavirus Cases | TODAY

Drug company

Coronavirus vaccine: Moderna vaccine shows promising results, stock jumps

Coronavirus vaccine: Moderna vaccine shows promising results, stock jumps

Yahoo Finance's Anjalee Khemlani joins Zack Guzman to discuss the outlook for